Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1007/S00246-023-03265-Z | ||||
| Año | 2023 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Left ventricular shape alterations predict cardiovascular outcomes and have been observed in children born preterm and after fetal growth restriction (FGR). The aim was to investigate whether left ventricular shape is altered in adolescents born very preterm and if FGR has an additive effect. Adolescents born very preterm due to verified early-onset FGR and two control groups with birthweight appropriate for gestational age (AGA), born at similar gestational age and at term, respectively, underwent cardiac MRI. Principal component analysis was applied to find the modes of variation best explaining shape variability for end-diastole, end-systole, and for the combination of both, the latter indicative of function. Seventy adolescents were included (13-16 years; 49% males). Sphericity was increased for preterm FGR versus term AGA for end-diastole (36[0-60] vs - 42[- 82-8]; p = 0.01) and the combined analysis (27[- 23-94] vs - 51[- 119-11]; p = 0.01), as well as for preterm AGA versus term AGA for end-diastole (30[- 56-115] vs - 42[- 82-8]; p = 0.04), for end-systole (57[- 29-89] vs - 30[- 79-34]; p = 0.03), and the combined analysis (44[- 50-145] vs - 51[- 119-11]; p = 0.02). No group differences were observed for left ventricular mass or ejection fraction (all p & GE; 0.33). Sphericity was increased after very preterm birth and exacerbated by early-onset FGR, indicating an additive effect to that of very preterm birth on left ventricular remodeling. Increased sphericity may be a prognostic biomarker of future cardiovascular disease in this cohort that as of yet shows no signs of cardiac dysfunction using standard clinical measurements.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Liefke, Jonas | - |
Lund Univ - Suecia
Skane Univ Hosp - Suecia Institutionen för Kliniska Vetenskaper, Lund - Suecia Skånes universitetssjukhus - Suecia |
| 2 | Sepulveda-Martinez, Alvaro | - |
Lund Univ - Suecia
Hosp Clin Univ Chile - Chile Institutionen för Kliniska Vetenskaper, Lund - Suecia Hospital Clínico Universidad de Chile - Chile |
| 3 | Shakya, Snehlata | - |
Lund Univ - Suecia
Institutionen för Kliniska Vetenskaper, Lund - Suecia |
| 4 | Ehrenborg, Katarina Steding | - |
Lund Univ - Suecia
Institutionen för Kliniska Vetenskaper, Lund - Suecia |
| 5 | Arheden, Hakan | - |
Lund Univ - Suecia
Institutionen för Kliniska Vetenskaper, Lund - Suecia |
| 6 | Morsing, Eva | - |
Lund Univ - Suecia
Skane Univ Hosp - Suecia Institutionen för Kliniska Vetenskaper, Lund - Suecia Skånes universitetssjukhus - Suecia |
| 7 | Ley, David | - |
Lund Univ - Suecia
Skane Univ Hosp - Suecia Institutionen för Kliniska Vetenskaper, Lund - Suecia Skånes universitetssjukhus - Suecia |
| 8 | Heiberg, Einar | Hombre |
Lund Univ - Suecia
Institutionen för Kliniska Vetenskaper, Lund - Suecia Wallenberg Centre for Molecular Medicine - Suecia |
| 9 | Hedstrom, Erik | Hombre |
Lund Univ - Suecia
Skane Univ Hosp - Suecia Institutionen för Kliniska Vetenskaper, Lund - Suecia Skånes universitetssjukhus - Suecia |
| Agradecimiento |
|---|
| Open access funding provided by Lund University. Funding was received from the Swedish Heart-Lung Foundation [20180510, 20200179, 20210606, and 20220575 ErH; 20200808 DL], Swedish Research Council grant [2020-01236 DL], the Swedish governmental funding of clinical research (ALF) [ErH, DL], Region Skåne [ErH, DL], and Skåne University Hospital [ErH, DL]. |